Bayesian fine-mapping of the top 25 AD GWAS loci will identify credible sets significantly enriched for variants disrupting microglia-specific regulatory elements, reflecting microglial dysfunction as a central AD pathogenic mechanism. Credible sets at loci with known effector genes (APOE, TREM2, PLCG2) will be smaller (<10 variants) due to stronger functional constraints, while novel loci will have larger sets requiring integration with epigenomic data to prioritize causal variants. The highest
## Mechanistic Overview
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to Amyloid Clearance starts from the claim that modulating TREM2 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "Background and Rationale Alzheimer's disease (AD) represents the most common cause of dementia worldwide, yet therapeutic strategies targeting amyloid-β have shown limited clinical efficacy, highlighting the need
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
TREM2Neuroinflammation
Convergent signals
TREM2 recurs across 2 selected hypotheses with aligned directionality in neuroinflammation.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
4/11
dimensions won
AD fine-mapping identifies causal varian
7/11
dimensions won
H1: TREM2 Agonism to Redirect APOE4-Enha
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.86
0.57
Evidence
0.72
0.52
Novelty
0.68
0.57
Feasibility
0.85
0.69
Impact
0.00
0.64
Druggability
0.00
0.80
Safety
0.00
0.55
Competition
0.00
0.60
Data
0.00
0.70
Reproducible
0.00
0.39
KG Connect
0.50
0.91
Score Breakdown
Dimension
AD fine-mapping identifies cau
H1: TREM2 Agonism to Redirect
Mechanistic
0.860
0.573
Evidence
0.720
0.520
Novelty
0.680
0.568
Feasibility
0.850
0.689
Impact
0.000
0.642
Druggability
0.000
0.800
Safety
0.000
0.550
Competition
0.000
0.600
Data
0.000
0.700
Reproducible
0.000
0.390
KG Connect
0.500
0.911
Evidence
AD fine-mapping identifies causal variants in microglia-spec
No evidence citations yet
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from
No evidence citations yet
Debate Excerpts
H1: TREM2 Agonism to Redirect APOE4-Enhanced Micro
6 rounds · quality: 0.95
Theorist
# Analysis of TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
## Mechanistic Evaluation
The hypothesis presents a sophisticated model of TREM2-mediated neuroimmune crosstalk wi...
Skeptic
# Critical Evaluation: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
## Weakest Assumptions of the Hypothesis
### 1. **Exclusive Microglial Expression of TREM2**
The hypothes...
Domain Expert
# Translational Feasibility Assessment: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
## Executive Summary
The hypothesis integrates well-established microglial biology with ...
Theorist
# THEORIST — Round 4 — RESPONSE TO SKEPTIC
## Addressing the Major Critiques
I appreciate the careful deconstruction of my hypothesis. The skeptic raises two substantive objections that deserve di...